(Q45876980)

17 December 2017

title

A canine minidystrophin is functional and therapeutic in mdx mice (English)

1 reference

17 December 2017

author name string

B Wang

1

1 reference

17 December 2017

J Li

2

1 reference

17 December 2017

C Qiao

3

1 reference

17 December 2017

C Chen

4

1 reference

17 December 2017

P Hu

5

1 reference

17 December 2017

X Zhu

6

1 reference

17 December 2017

L Zhou

7

1 reference

17 December 2017

J Bogan

8

1 reference

17 December 2017

J Kornegay

9

1 reference

17 December 2017

X Xiao

10

1 reference

17 December 2017

publication date

24 April 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

15

1 reference

17 December 2017

page(s)

1099-1106

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2008.70

exact match

0 references

cites work

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

7 January 2021

inferred from DOI database lookup

Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

7 January 2021

inferred from DOI database lookup

mdx muscle pathology is independent of nNOS perturbation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.70

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/GT.2008.70

1 reference

17 December 2017

Dimensions Publication ID

1032192003

0 references

Fatcat ID

release_332swbynfvgdlht2x5wivo4zpe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/332swbynfvgdlht2x5wivo4zpe

24 November 2022

mapped directly with Wikidata item

PubMed ID

18432277

1 reference

17 December 2017